Welcome To Nutrify Snips

Nutra News made Easy

  • Fermented Mushroom Extract Protects Gut Barrier and Reduces Inflammation

    A new study highlights the potential of Pleurotus eryngii mushroom fermentation supernatant (FS-PEWS) in safeguarding intestinal health. Using an in vitro Caco-2 cell model and ex vivo colonic biopsies, researchers found that FS-PEWS counteracted sodium deoxycholate (SDC)-induced gut barrier damage by restoring key tight junction proteins ZO-1 and claudin-1. The supernatant also reduced pro-inflammatory cytokines,… Read More


  • Phytopreventive antihypercholesterolmic and antilipidemic perspectives of zedoary (Curcuma Zedoaria Roscoe.) herbal tea

    Zedoary, or white turmeric, is a plant related to ginger and turmeric, traditionally used for its medicinal properties. In this study, researchers prepared herbal teas using varying amounts of dried zedoary rhizome powder and had thirty male participants with mild high cholesterol consume these teas daily for two months. The results showed that participants experienced… Read More


  • Purple Tea: A Natural Solution for Weight Management and Fat Metabolism

    Purple tea extract (PTE), a unique Kenyan tea variety rich in anthocyanins, EGCG, and GHG, offers promising benefits for weight management. Research shows that PTE significantly suppresses body weight gain, liver fat, and abdominal fat by enhancing carnitine palmitoyltransferase (CPT) 1A expression, a key enzyme in fat metabolism. Additionally, PTE reduces fat absorption, as demonstrated… Read More


  • PanTheryx’s Relesium- A Gut Health Supplement for GLP-1 Users

    Nutrition and biotechnology company PanTheryx has introduced Relesium, a gut health supplement designed to provide immediate relief and long-term support for gastrointestinal side effects caused by GLP-1 weight-loss medications such as Ozempic, Wegovy, and Mounjaro. GLP-1 drugs, commonly used for weight management, can cause nausea, diarrhea, constipation, and bloating. PanTheryx CEO Tom Feeley emphasized the… Read More


  • Curcumin Supplementation as a Preventive Strategy Against Tamoxifen-Induced Nonalcoholic Fatty Liver Disease in ER+ Breast Cancer Patients

    The study titled “Curcumin Supplementation as a Preventive Strategy Against Tamoxifen-Induced Nonalcoholic Fatty Liver Disease in ER+ Breast Cancer Patients: A Triple-Blind Randomized Placebo-Controlled Trial” demonstrated several positive outcomes. Notably, only 13.6% of patients receiving curcumin experienced an increase in NAFLD grade, compared to 54.5% in the placebo group, indicating that curcumin significantly slowed liver… Read More


Join the biggest platform for nutraceuticals